Akesis, LLC Report issue

For profit Phase 3
Founded: Clover SC United States (2012)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2012
NCT01788384
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4